Immuron Limited logo

Immuron Limited

ASX:IMC.AX

Overview | Financials
Company Name Immuron Limited
Symbol IMC.AX
Currency AUD
Price 0.077
Market Cap 17,644,165
Dividend Yield 0%
52-week-range 0.065 - 0.17
Industry Biotechnology
Sector Healthcare
CEO Mr. Steven George Lydeamore CPA, CPA, M.B.A., MBA
Website https://www.immuron.com.au

An error occurred while fetching data.

About Immuron Limited

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and

Related Stocks

ImExHS Limited logo

ImExHS Limited

IME.AX

0.45 AUD

ECS Botanics Holdings Ltd logo

ECS Botanics Holdings Ltd

ECS.AX

0.016 AUD

Amplia Therapeutics Limited logo

Amplia Therapeutics Limited

ATX.AX

0.135 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD